APA (7th ed.) Citation

Nimitvilai, S., Suputtamongkol, Y., Poolvivatchaikarn, U., Rassamekulthana, D., Rongkiettechakorn, N., Mungaomklang, A., . . . Sawaengdee, W. (2022). A randomized controlled trial of combined ivermectin and zinc sulfate versus combined hydroxychloroquine, darunavir/ritonavir, and zinc sulfate among adult patients with asymptomatic or mild coronavirus-19 infection. Journal of Global Infectious Diseases, 14(2), 69. https://doi.org/10.4103/jgid.jgid_281_21

Chicago Style (17th ed.) Citation

Nimitvilai, Sireethorn, et al. "A Randomized Controlled Trial of Combined Ivermectin and Zinc Sulfate Versus Combined Hydroxychloroquine, Darunavir/ritonavir, and Zinc Sulfate Among Adult Patients with Asymptomatic or Mild Coronavirus-19 Infection." Journal of Global Infectious Diseases 14, no. 2 (2022): 69. https://doi.org/10.4103/jgid.jgid_281_21.

MLA (9th ed.) Citation

Nimitvilai, Sireethorn, et al. "A Randomized Controlled Trial of Combined Ivermectin and Zinc Sulfate Versus Combined Hydroxychloroquine, Darunavir/ritonavir, and Zinc Sulfate Among Adult Patients with Asymptomatic or Mild Coronavirus-19 Infection." Journal of Global Infectious Diseases, vol. 14, no. 2, 2022, p. 69, https://doi.org/10.4103/jgid.jgid_281_21.